You are here

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

Last updated on February 20, 2019

FOR MORE INFORMATION
Study Location
Rheumatology Associates, PC
Birmingham, Alabama, 35205 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Psoriatic Arthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Previous participation in qualifying PsA study involving tofacitinib

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Time from End of Study visit of qualifying study is >3 months.

- Pregnant female, breastfeeding female or female of childbearing potential unwilling or
unable to use highly effective birth control for duration of study and one ovulatory
cycle thereafter.

Sub-study Inclusion Criteria:

- Subjects who have completed at least 24 months of treatment with tofacitinib in the
extension study

- Subjects on a stable oral dose of methotrexate (maximum dose 20 mg per week)

Sub-study Exclusion Criteria:

-Subjects who are receiving methotrexate by a route other than oral

NCT01976364
Pfizer
Active, not recruiting
Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Psoriatic Arthritis, Psoriasis, Papulosquamous Skin Diseases
NCT00293722
All Genders
18+
Years
Toerwang-Samerberg,
Psoriatic Arthritis
NCT01976364
All Genders
18+
Years
Multiple Sites
Psoriatic Arthritis
NCT03486457
All Genders
18+
Years
Multiple Sites
Ankylosing Spondylitis, Psoriatic Arthritis, Rheumatoid Arthritis
NCT00751387
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now